Skip to content

Homoeopathic Treatment for Osteoarthritis

A synopsis on Assessment of Likelihood Ratio of four symptoms of Medorrhinum in Patients of Osteoarthritis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/042995
Enrollment
100
Registered
2022-06-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M199- Osteoarthritis, unspecified site

Interventions

Intervention1: Medorrhinum: Dose: As required for the patient Frequency: As per the need of patient Route of administration: Oral Total duration: 6 months

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from osteoarthritis of any joint verified by clinical examination and X-Ray. 2. Patient aged 35-75 year, both male and female. 3. Subjects of all socio-economic status, all religions. 4. Ability to read Bengali, Hindi and/or English. 5. Patients giving written consent to participate in this study. 6. Subjects who agree to comply with the protocol. 7. Subjects who agree to undergo laboratory investigation whenever required.

Exclusion criteria

Exclusion criteria: 1. Patients below the age of 35 years. 2. Patients with increased serum uric acid level, or positive rheumatoid factors or any clinical evidence of psoriatic arthritis. 3. Patients with unstable psychiatric disorder. 4. Pregnant or lactating women. 5. Immune compromised state. 6. Substance abuse and/or dependence. 7. Uncontrolled hypertension, diabetes or any other systemic illness or life-threatening diseases. 8. Cases already undergoing homoeopathic treatment for any chronic illness. 9. Unwilling to participate or to comply with the study requirements, too unwell to take part, or declined to provide consent.

Design outcomes

Primary

MeasureTime frame
Numeric rating scale measuring intensity of pain. ‘0’ being ‘no pain’ and ‘10’ being ‘worst pain imaginable’. The patient picks or draws a circle around the number that best describes the pain intensity.Timepoint: Baseline 3 months 6 months

Secondary

MeasureTime frame
EQ-5D-5L questionnaire is a quality of life questionnaire. It is used for evaluating the health status and stability of the patient. Consists of 2 pages- the EQ-5D-5L descriptive system and the EQ Visual Analogue Scale (EQ VAS). The descriptive system comprises 5 dimensions- mobility, self care, usual activities, pain/discomfort, anxiety/depression.Timepoint: Baseline, 3 months, 6 months

Countries

India

Contacts

Public ContactDr Swapan Paul

National Institute of Homoeopathy

drspaul.2007@gmail.com9830148968

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026